Changes in metformin pharmacokinetics after intravenous and oral administration to rats with short‐term and long‐term diabetes induced by streptozotocin

This publication has 33 references indexed in Scilit:

• Mechanisms and Outcomes of Drug- and Toxicant-Induced Liver Toxicity in Diabetes
  Critical Reviews in Toxicology, 2007
• Pharmacokinetics of Chlorzoxazone in Rats with Diabetes: Induction of CYP2E1 on 6-Hydroxychlorzoxazone Formation
  Journal of Pharmaceutical Sciences, 2006
• Effects of enzyme inducers and inhibitors on the pharmacokinetics of metformin in rats: involvement of CYP2C11, 2D1 and 3A1/2 for the metabolism of metformin
  British Journal of Pharmacology, 2006
• COMPARISON OF MOUSE AND RAT CYTOCHROME P450-MEDIATED METABOLISM IN LIVER AND INTESTINE
  Drug Metabolism and Disposition, 2006
• Pharmacokinetics of oltipraz in rat models of diabetes mellitus induced by alloxan or streptozotocin
  Life Sciences, 2006
• Clinical Pharmacokinetics of Metformin
  Clinical Pharmacokinetics, 1996
• Pharmacokinetics and pharmacodynamics of furosemide in protein-calorie malnutrition
  Journal of Pharmacokinetics and Biopharmaceutics, 1993
• Evaluation of potential causes for the incomplete bioavailability of furosemide: Gastric first-pass metabolism
  Journal of Pharmacokinetics and Biopharmaceutics, 1983
• Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve
  Journal of Pharmacokinetics and Biopharmaceutics, 1978
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
  Analytical Biochemistry, 1976